HMC Capital Ltd (ASX: HMC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

HMC Capital Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.34 billion
P/E Ratio 70.96
Dividend Yield 3.69%
Shares Outstanding 412.62 million
Earnings per share 0.046
Dividend per share 0.12
Year To Date Return -14.90%
Earnings Yield 1.41%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • HMC Capital Ltd (ASX: HMC)
    Latest News

    Person on a tablet with buy and sell options for a stock on the screen.
    Financial Shares

    This ASX financials stock just soared 11% on results and is tipped to keep rising

    This could be one of the sector's top buys.

    Read more »

    A man in a business suit peers through binoculars as two businesswomen stand beside him looking straight ahead at the camera.
    Earnings Results

    HMC Capital share price on watch as FY26 earnings meet guidance, FY27 growth targeted

    The company has set sights on 16% underlying earnings growth for FY27.

    Read more »

    Buy now written on a red key with a shopping trolley on an Apple keyboard.
    Broker Notes

    Three ASX shares with fresh buy recommendations to target this week

    These shares have more than 20% upside.

    Read more »

    Two smiling work colleagues discuss an investment at their office.
    Share Gainers

    Why DigiCo, HMC Capital, Infratil, and Qantas shares are taking off today

    These shares are having a strong session on hump day. What's going on?

    Read more »

    Value spelt out with a magnifying glass.
    Value Investing

    After crashing 57%, this ASX value stock looks filthy cheap with a P/E of just 7

    This business could be one of the cheapest buys on the ASX!

    Read more »

    Man going down a red arrow, symbolising a sliding share price.
    52-Week Lows

    4 ASX All Ords shares at 52-week lows. Should you buy?

    Let's ask the experts.

    Read more »

    man looks at phone while disappointed
    Broker Notes

    Buy, hold, sell: HMC Capital, Ramsay Health Care, and Sigma shares

    Morgans has given its verdict on these shares this month.

    Read more »

    A man closely watches a clock.
    Dividend Investing

    35 ASX All Ords shares with ex-dividend dates next week

    It's the final day of earnings season.

    Read more »

    A padlock wrapped around a wad of Australian $20 and $50 notes, indicating money locked up.
    Financial Shares

    How does Bell Potter view these ASX financials stocks after earnings season?

    The broker views one of these stocks as a clear buy.

    Read more »

    Man holding out Australian dollar notes, symbolising dividends.
    Dividend Investing

    Guess which ASX stock could pay a 9% dividend yield in 2027

    Bell Potter thinks patient income investors should be buying this stock.

    Read more »

    Disappointed man with his head on his hand looking at a falling share price his a laptop.
    Share Fallers

    Why Bougainville Copper, Brainchip, Challenger, and HMC Capital shares are falling today

    These shares are starting the week in the red. But why?

    Read more »

    Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
    Dividend Investing

    1 ASX dividend stock down 64% I'd buy right now

    This business can offer investors a number of positives…

    Read more »

    Frequently Asked Questions

    Yes, HMC Capital has historically paid largely fully franked shareholder dividends twice a year.

    HMC Capital generally pays its shareholder dividends in April and October.

    HMC Capital Ltd listed on the ASX on 14 October 2019.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    01 Sep 2026 $0.0600 0.00% Final 07 Oct 2026
    03 Mar 2026 $0.0600 16.67% Interim 09 Apr 2026
    26 Aug 2025 $0.0600 0.00% Final 30 Sep 2025
    25 Feb 2025 $0.0600 100.00% Interim 01 Apr 2025
    27 Aug 2024 $0.0600 70.00% Final 02 Oct 2024
    26 Feb 2024 $0.0600 0.00% Interim 02 Apr 2024
    29 Aug 2023 $0.0600 10.00% Final 04 Oct 2023
    01 Mar 2023 $0.0600 100.00% Interim 06 Apr 2023
    01 Sep 2022 $0.0600 100.00% Final 07 Oct 2022
    01 Mar 2022 $0.0600 100.00% Interim 07 Apr 2022
    02 Sep 2021 $0.0600 50.00% Final 01 Oct 2021
    02 Mar 2021 $0.0600 100.00% Interim 17 Mar 2021
    03 Sep 2020 $0.0750 100.00% Final 18 Sep 2020
    04 Mar 2020 $0.0450 100.00% Interim 19 Mar 2020

    HMC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About HMC Capital Ltd

    HMC Capital Ltd (ASX: HMC) is a diversified alternative asset manager with more than $19.5 billion of assets under management (AUM) as of February 2026, spanning real estate, private equity, energy transition, private credit, and digital infrastructure.

    Several listed real estate investment trusts (REITs), including HomeCo Daily Needs REIT, HealthCo Healthcare and Wellness REIT, and DigiCo Infrastructure REIT, operate under the company structure alongside several unlisted funds.

    HMC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    11 Sep 2026 $3.25 $-0.20 -5.80% 1,157,958 $3.32 $3.39 $3.24
    10 Sep 2026 $3.45 $-0.01 -0.29% 1,229,011 $3.44 $3.48 $3.40
    09 Sep 2026 $3.46 $0.14 4.22% 1,254,837 $3.34 $3.47 $3.31
    08 Sep 2026 $3.32 $-0.06 -1.78% 1,321,714 $3.36 $3.38 $3.24
    07 Sep 2026 $3.38 $0.02 0.60% 999,715 $3.30 $3.42 $3.30
    04 Sep 2026 $3.36 $0.26 8.39% 1,938,505 $3.16 $3.38 $3.16
    03 Sep 2026 $3.10 $-0.04 -1.27% 1,520,485 $3.14 $3.24 $3.10
    02 Sep 2026 $3.14 $-0.06 -1.88% 1,809,882 $3.15 $3.23 $3.09
    01 Sep 2026 $3.20 $-0.05 -1.54% 1,543,211 $3.60 $3.60 $3.11
    31 Aug 2026 $3.25 $-0.09 -2.69% 1,634,515 $3.28 $3.36 $3.23
    28 Aug 2026 $3.34 $-0.04 -1.18% 1,917,195 $3.54 $3.54 $3.30
    27 Aug 2026 $3.38 $0.12 3.68% 7,847,968 $3.40 $3.59 $3.32
    26 Aug 2026 $3.26 $0.33 11.26% 6,878,782 $3.02 $3.46 $2.92
    25 Aug 2026 $2.93 $0.01 0.34% 357,550 $2.92 $2.95 $2.89
    24 Aug 2026 $2.92 $-0.02 -0.68% 558,362 $2.98 $2.99 $2.90
    21 Aug 2026 $2.94 $-0.06 -2.00% 527,384 $3.05 $3.05 $2.91
    20 Aug 2026 $3.00 $0.01 0.33% 1,515,789 $2.97 $3.03 $2.96
    19 Aug 2026 $2.99 $-0.01 -0.33% 973,671 $3.00 $3.01 $2.94
    18 Aug 2026 $3.00 $-0.02 -0.66% 472,586 $3.01 $3.05 $2.99
    17 Aug 2026 $3.02 $-0.01 -0.33% 584,470 $3.04 $3.05 $2.98
    14 Aug 2026 $3.03 $-0.03 -0.98% 240,969 $3.07 $3.08 $3.02

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    27 Aug 2026 Christopher Roberts Buy 8,560 $28,932
    Conversion of securities.
    27 Aug 2026 Christopher Roberts Exercise 8,560 $28,932
    Conversion of securities.
    27 Aug 2026 Gregory (Greg) Hayes Exercise 13,547 $45,788
    Conversion of securities.
    27 Aug 2026 Gregory (Greg) Hayes Buy 13,547 $45,788
    Conversion of securities.
    27 Aug 2026 Fiona Pak-Poy Exercise 7,846 $26,519
    Conversion of securities.
    27 Aug 2026 Fiona Pak-Poy Buy 7,846 $26,519
    Conversion of securities.
    27 Aug 2026 Christopher Saxon Buy 17,833 $60,275
    Conversion of securities.
    27 Aug 2026 Christopher Saxon Exercise 17,833 $60,275
    Conversion of securities.
    27 Aug 2026 Kelly O'Dwyer Exercise 10,700 $36,166
    Conversion of securities.
    27 Aug 2026 Kelly O'Dwyer Buy 10,700 $36,166
    Conversion of securities.
    27 Aug 2026 Susan Roberts Exercise 9,986 $33,752
    Conversion of securities.
    27 Aug 2026 Susan Roberts Buy 9,986 $33,752
    Conversion of securities.
    25 Feb 2026 Susan Roberts Exercise 9,986 $28,060
    Conversion of securities. 9,986 rights
    25 Feb 2026 Susan Roberts Buy 9,986 $28,060
    Conversion of securities.
    25 Feb 2026 Kelly O'Dwyer Exercise 10,700 $30,067
    Conversion of securities. 10,700 rights
    25 Feb 2026 Kelly O'Dwyer Buy 10,700 $30,067
    Conversion of securities.
    25 Feb 2026 Fiona Pak-Poy Exercise 7,846 $22,047
    Conversion of securities. 7,846 rights
    25 Feb 2026 Fiona Pak-Poy Buy 7,846 $22,047
    Conversion of securities.
    25 Feb 2026 Christopher Saxon Exercise 17,833 $50,110
    Conversion of securities. 17,833 rights
    25 Feb 2026 Christopher Saxon Buy 17,833 $50,110
    Conversion of securities.
    25 Feb 2026 Gregory (Greg) Hayes Exercise 7,846 $22,047
    Conversion of securities. 13,547 rights
    25 Feb 2026 Gregory (Greg) Hayes Buy 7,846 $22,047
    Conversion of securities.
    25 Feb 2026 Christopher Roberts Exercise 8,560 $24,053
    Conversion of securities. 8,560 rights
    25 Feb 2026 Christopher Roberts Buy 8,560 $24,053
    Conversion of securities.
    27 Nov 2025 Gregory (Greg) Hayes Issued 15,692 $55,706
    Director remuneration. 21,393 rights
    27 Nov 2025 Fiona Pak-Poy Issued 15,692 $55,706
    Director remuneration. 15,692 rights
    27 Nov 2025 David Di Pilla Issued 595,924 $2,115,530
    Issue of securities. 1,639,348 performance rights
    27 Nov 2025 Christopher Saxon Issued 35,666 $126,614
    Director remuneration. 35,666 rights
    27 Nov 2025 Susan Roberts Issued 19,972 $70,900
    Director remuneration. 19,972 rights
    27 Nov 2025 Christopher Roberts Issued 17,120 $60,776
    Director remuneration. 17,120 rights
    27 Nov 2025 Kelly O'Dwyer Issued 21,400 $75,970
    Director remuneration. 21,400 rights
    21 Nov 2025 Kelly O'Dwyer Buy 32,959 $104,761
    On-market trade. 1000 Prior Holding
    30 Sep 2025 David Di Pilla Expiry 179,616 $571,178
    As advised by the company. Lapsed, 10,43,424 Rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Nov 2024
    Dr Roberts has over 40 years of experience in the medical device industry, serving a few senior management positions. He was the former CEO of Cochlear from 2004 to 2015 and is presently a member of the Cochlear Foundation Board, Non-Executive Director of HCW Funds Management Limited (the responsible entity of the HealthCo Healthcare & Wellness REIT, a Non-Executive Director of Sigma Healthcare Limited, Clarity Pharmaceuticals Limited, Atmo Biosciences Ltd, Centenary Institute of Medical Research and Nutromics Pty Ltd. He was also the Executive Vice President of ResMed from 1992 to 2003, and a director until 2017. Chris was a former Chair of Research Australia from 2004 to 2010.
    Mr Gregory (Greg) John Hayes Non-Executive Director Sep 2019
    Mr Hayes is currently a Non-Executive Director of Aurrum Holdings Pty Ltd and Future Secure AI Inc. Having worked across industries including property, infrastructure, energy and logistics, his skills and experience include strategy, finance, mergers and acquisitions and strategic risk management, in listed companies with global operations. He was previously a Non-Executive Director of Ingenia Communities, Non-Executive Director of HomeCo Daily Needs REIT, Chief Financial Officer and Executive Director of Brambles Limited, Chief Executive Officer and Group Managing Director of Tenix Pty Ltd, Chief Financial Officer and later interim Chief Executive Officer of the Australian Gaslight Company, Chief Financial Officer Australia and New Zealand of Westfield Holdings, Executive General Manager, Finance of Southcorp Limited. He was a director of Ingenia Communities (until 1 July 2024) and HomeCo Daily Needs REIT (until 13 February 2025).
    Ms Fiona Jane Pak-Poy Non-Executive Director Nov 2024
    Ms Pak-Poy is the Chair and Non-Executive director of Tyro Payments Limited. She is on the Board of Trustees and Investment Committee for HMC Capital Partners Fund 1 and is a member of the Business Advisory Council for Anacacia Capital. Fiona has over 30 years of experience in a variety of industries, for companies ranging from startups to listed companies, government entities and not-for-profits. She has served on various boards, including WiseTech Global MYOB, Isentia, Novotech, PageUp People, StatePlus and SIRCA (the Securities Research Centre of South-East Asia). She served on the ASIC director Advisory Panel and the Board of Innovation Australia. Previously She was a strategy consultant for the Boston Consulting Group in the US and Australia and was a General Partner in an Australian venture capital fund focused on technology startups. Fiona is a mentor for the Minerva Network, a member of Chief Executive Women and a Fellow of the Australian Institute of Company Directors. She is the Member of the Sustainability Committee.
    Mr David Anthony Di Pilla Chief Executive OfficerManaging Director Oct 2017
    Mr Pilla has over 30 years of experience in investment banking, strategic advisory & consulting and corporate leadership as a Director and CEO. During his 20-year investment banking career David was Managing Director of UBS Investment Bank for over 15 years and during this time led some of Australia landmark transactions across corporate M&A, Equity & Debt Capital Markets. Prior to his time at UBS, David reached the position of Vice President, Investment Banking at JP Morgan. He is a director of HomeCo Daily Needs REIT (appointed on 18 September 2020), HealthCo Healthcare and Wellness REIT (appointed on 28 July 2021), and HMC Digital Infrastructure Limited, which forms part of DigiCo Infrastructure REIT (appointed on 1 November 2024).
    Mr Christopher Saxon Non-Executive DirectorNon-Executive Chairman Sep 2019
    Mr Saxon is an Australian lawyer and was, until 2019, a partner with global law firm Baker McKenzie. His practice included mergers and acquisition (M&A) transactions across a range of sectors, notably energy (gas, electricity, renewable), industrials, infrastructure and mining. He has served as lead adviser on government restructuring transactions, privatisations, trade sales, mergers and acquisitions, and infrastructure projects. Chris served as Chair of Baker McKenzie Australia for five years (2012-2017) and held leadership roles within the firm.
    Hon Kelly Megan O'Dwyer Non-Executive Director Nov 2020
    Hon O'Dwyer is a Non-Executive Director of EQT Holdings Limited, HealthCo Healthcare and Wellness REIT, DigiCo Infrastructure REIT, Barrenjoey Capital Partners Group Holdings Pty Ltd and the National Reconstruction Fund Corporation. Kelly previously served in the Australian Parliament as a Senior Cabinet Minister holding a few key economic portfolios including Minister for Jobs and Industrial Relations; Minister for Revenue and Financial Services; Minister for Small Business; and Assistant Treasurer. She also served on the Cabinet Budget Committee (the Expenditure Review Committee) and held the portfolios of Minister for Women; as well as Minister Assisting the Prime Minister with the Public Service. Prior to entering Parliament, Kelly worked in law, government and finance and brought insights across a range of sectors including funds management, superannuation, workplace relations, foreign investment, law and banking. She is a director of EQT Holdings Limited (appointed on 29 March 2021), HealthCo Healthcare and Wellness REIT (appointed on 1 August 2021), HMC Digital Infrastructure Limited, which forms part of DigiCo Infrastructure REIT (appointed on 1 November 2024), and Magellan Financial Group Ltd (appointed on 1 July 2026). She is the Chair of Sustainability Committee.
    Ms Susan Roberts Non-Executive Director Nov 2022
    Ms Roberts is an experienced director and CEO with over 30 years in the financial services, investment and insurance industries. Her current roles include Chair of Audit for AIG Australia and Teachers Health, and she is a director of Metlife Australia. Susan has a technical actuarial and investment background coupled with risk management, business strategy, governance and stakeholder management skills. She has commercial and financial executive experience, including CEO and Managing Director of Lazard Asset Management Pacific, and Director, Strategy at Lend Lease Investment Services. She has previously served as a Non-Executive Director of Maple Brown Abbott and as Chair of the Audit and Risk, and Claims Committee for Zurich Australia Superannuation. Susan was also Chair of the Investor Working Group for the 30% Club in Australia. She is the member of the Sustainability Committee.
    Mr Andrew Selim Company SecretaryGeneral Counsel
    -
    Andrew Selim Company SecretaryGeneral Counsel
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Citicorp Nominees Pty Limited 133,366,340 32.32%
    Home Investment Consortium Trust 79,535,204 19.28%
    HSBC Custody Nominees (Australia) Limited 1 52,353,491 12.69%
    J P Morgan Nominees Australia Pty Limited 34,797,438 8.43%
    Netwealth Investments Limited 12,628,547 3.06%
    BNP Paribas NOMS PTY LTD 5,079,842 1.23%
    UBS Nominees Pty Ltd 2,920,370 0.71%
    HSBC Custody Nominees (Australia) Limited 2,494,385 0.60%
    CW Property Nominees Pty Ltd 2,238,806 0.54%
    BNP Paribas Nominees Pty Ltd 1 2,154,854 0.52%
    BNP Paribas Nominees Pty Ltd 2,145,007 0.52%
    Aldaoud Pty Ltd 2,000,000 0.48%
    BNP Paribas Noms (Nz) Ltd 1,941,529 0.47%
    Pacific Custodians Pty Limited 1,828,462 0.44%
    Mat Family Foundation Pty Ltd 1,700,000 0.41%
    BNP Paribas Nominees Pty Ltd 2 1,666,203 0.40%
    SG Foundation Investments Pty Ltd 1,071,014 0.26%
    David Payton Pty Ltd 968,522 0.23%
    Mr Amer Akkari 864,344 0.21%
    Ruth Payton Foundation Limited 835,299 0.20%

    Profile

    since

    Note